nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—liver cancer	0.473	0.727	CbGaD
Rosiglitazone—ALB—liver cancer	0.178	0.273	CbGaD
Rosiglitazone—CYP2C8—Sorafenib—liver cancer	0.0349	0.231	CbGbCtD
Rosiglitazone—CYP2C19—Sorafenib—liver cancer	0.0293	0.194	CbGbCtD
Rosiglitazone—CYP1A2—Sorafenib—liver cancer	0.027	0.179	CbGbCtD
Rosiglitazone—CYP2C9—Sorafenib—liver cancer	0.0243	0.161	CbGbCtD
Rosiglitazone—CYP2D6—Sorafenib—liver cancer	0.0223	0.147	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—liver cancer	0.0135	0.0893	CbGbCtD
Rosiglitazone—Ischaemia—Sorafenib—liver cancer	0.00424	0.0683	CcSEcCtD
Rosiglitazone—Pioglitazone—PPARG—liver cancer	0.00279	1	CrCbGaD
Rosiglitazone—Pleural effusion—Sorafenib—liver cancer	0.00202	0.0326	CcSEcCtD
Rosiglitazone—Myocardial ischaemia—Sorafenib—liver cancer	0.00193	0.031	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Sorafenib—liver cancer	0.00129	0.0207	CcSEcCtD
Rosiglitazone—Hepatic failure—Sorafenib—liver cancer	0.00125	0.0201	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Sorafenib—liver cancer	0.00124	0.02	CcSEcCtD
Rosiglitazone—Cardiac failure—Sorafenib—liver cancer	0.00115	0.0185	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Sorafenib—liver cancer	0.00101	0.0162	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000859	0.0138	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Sorafenib—liver cancer	0.000854	0.0138	CcSEcCtD
Rosiglitazone—Myocardial infarction—Sorafenib—liver cancer	0.000849	0.0137	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Sorafenib—liver cancer	0.000819	0.0132	CcSEcCtD
Rosiglitazone—Hyperlipidaemia—Epirubicin—liver cancer	0.000794	0.0128	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Sorafenib—liver cancer	0.000764	0.0123	CcSEcCtD
Rosiglitazone—Pleural effusion—Epirubicin—liver cancer	0.000747	0.012	CcSEcCtD
Rosiglitazone—Erythema multiforme—Sorafenib—liver cancer	0.000735	0.0118	CcSEcCtD
Rosiglitazone—Hyperlipidaemia—Doxorubicin—liver cancer	0.000735	0.0118	CcSEcCtD
Rosiglitazone—Cardiac disorder—Sorafenib—liver cancer	0.000722	0.0116	CcSEcCtD
Rosiglitazone—Immune system disorder—Sorafenib—liver cancer	0.000702	0.0113	CcSEcCtD
Rosiglitazone—Pleural effusion—Doxorubicin—liver cancer	0.000691	0.0111	CcSEcCtD
Rosiglitazone—Malnutrition—Sorafenib—liver cancer	0.000677	0.0109	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Epirubicin—liver cancer	0.000629	0.0101	CcSEcCtD
Rosiglitazone—Anaemia—Sorafenib—liver cancer	0.000626	0.0101	CcSEcCtD
Rosiglitazone—Angioedema—Sorafenib—liver cancer	0.000619	0.00996	CcSEcCtD
Rosiglitazone—Leukopenia—Sorafenib—liver cancer	0.000606	0.00976	CcSEcCtD
Rosiglitazone—Hypertension—Sorafenib—liver cancer	0.000584	0.00941	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.000582	0.00938	CcSEcCtD
Rosiglitazone—Myalgia—Sorafenib—liver cancer	0.000576	0.00928	CcSEcCtD
Rosiglitazone—Arthralgia—Sorafenib—liver cancer	0.000576	0.00928	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Sorafenib—liver cancer	0.000552	0.0089	CcSEcCtD
Rosiglitazone—Infection—Sorafenib—liver cancer	0.000549	0.00884	CcSEcCtD
Rosiglitazone—Fluid retention—Epirubicin—liver cancer	0.000543	0.00875	CcSEcCtD
Rosiglitazone—Nervous system disorder—Sorafenib—liver cancer	0.000542	0.00872	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Sorafenib—liver cancer	0.000541	0.00871	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Epirubicin—liver cancer	0.000509	0.0082	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000503	0.0081	CcSEcCtD
Rosiglitazone—Fluid retention—Doxorubicin—liver cancer	0.000503	0.00809	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Epirubicin—liver cancer	0.000478	0.00769	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Sorafenib—liver cancer	0.000477	0.00768	CcSEcCtD
Rosiglitazone—Fatigue—Sorafenib—liver cancer	0.000476	0.00767	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Epirubicin—liver cancer	0.000475	0.00765	CcSEcCtD
Rosiglitazone—Constipation—Sorafenib—liver cancer	0.000472	0.00761	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Doxorubicin—liver cancer	0.000471	0.00759	CcSEcCtD
Rosiglitazone—Hepatic failure—Epirubicin—liver cancer	0.000462	0.00744	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Epirubicin—liver cancer	0.000458	0.00738	CcSEcCtD
Rosiglitazone—Increased appetite—Epirubicin—liver cancer	0.000442	0.00712	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Doxorubicin—liver cancer	0.000442	0.00712	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Doxorubicin—liver cancer	0.00044	0.00708	CcSEcCtD
Rosiglitazone—Urticaria—Sorafenib—liver cancer	0.000439	0.00707	CcSEcCtD
Rosiglitazone—Hepatic failure—Doxorubicin—liver cancer	0.000428	0.00689	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Epirubicin—liver cancer	0.000426	0.00685	CcSEcCtD
Rosiglitazone—Cardiac failure—Epirubicin—liver cancer	0.000426	0.00685	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Epirubicin—liver cancer	0.000424	0.00683	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Doxorubicin—liver cancer	0.000424	0.00682	CcSEcCtD
Rosiglitazone—Increased appetite—Doxorubicin—liver cancer	0.000409	0.00659	CcSEcCtD
Rosiglitazone—Asthenia—Sorafenib—liver cancer	0.000396	0.00638	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Doxorubicin—liver cancer	0.000394	0.00634	CcSEcCtD
Rosiglitazone—Cardiac failure—Doxorubicin—liver cancer	0.000394	0.00634	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Doxorubicin—liver cancer	0.000392	0.00632	CcSEcCtD
Rosiglitazone—Pruritus—Sorafenib—liver cancer	0.000391	0.00629	CcSEcCtD
Rosiglitazone—Diarrhoea—Sorafenib—liver cancer	0.000378	0.00609	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Epirubicin—liver cancer	0.000371	0.00598	CcSEcCtD
Rosiglitazone—Dizziness—Sorafenib—liver cancer	0.000365	0.00588	CcSEcCtD
Rosiglitazone—Rash—Sorafenib—liver cancer	0.000348	0.00561	CcSEcCtD
Rosiglitazone—Dermatitis—Sorafenib—liver cancer	0.000348	0.0056	CcSEcCtD
Rosiglitazone—Headache—Sorafenib—liver cancer	0.000346	0.00557	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—liver cancer	0.000344	0.00553	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Epirubicin—liver cancer	0.000334	0.00537	CcSEcCtD
Rosiglitazone—Nausea—Sorafenib—liver cancer	0.000328	0.00528	CcSEcCtD
Rosiglitazone—Weight increased—Epirubicin—liver cancer	0.000327	0.00526	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Epirubicin—liver cancer	0.000324	0.00522	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000317	0.00511	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000309	0.00497	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Epirubicin—liver cancer	0.000303	0.00488	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—liver cancer	0.000302	0.00487	CcSEcCtD
Rosiglitazone—Sinusitis—Epirubicin—liver cancer	0.0003	0.00484	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—liver cancer	0.0003	0.00483	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000294	0.00473	CcSEcCtD
Rosiglitazone—Hepatitis—Epirubicin—liver cancer	0.000287	0.00463	CcSEcCtD
Rosiglitazone—Oedema peripheral—Epirubicin—liver cancer	0.000283	0.00456	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Epirubicin—liver cancer	0.000282	0.00455	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—liver cancer	0.00028	0.00451	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—liver cancer	0.000278	0.00447	CcSEcCtD
Rosiglitazone—Erythema multiforme—Epirubicin—liver cancer	0.000272	0.00438	CcSEcCtD
Rosiglitazone—Eye disorder—Epirubicin—liver cancer	0.000269	0.00432	CcSEcCtD
Rosiglitazone—Cardiac disorder—Epirubicin—liver cancer	0.000267	0.00429	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—liver cancer	0.000266	0.00428	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—liver cancer	0.000262	0.00422	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—liver cancer	0.000261	0.00421	CcSEcCtD
Rosiglitazone—Immune system disorder—Epirubicin—liver cancer	0.00026	0.00418	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—liver cancer	0.000251	0.00405	CcSEcCtD
Rosiglitazone—Malnutrition—Epirubicin—liver cancer	0.00025	0.00403	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—liver cancer	0.000248	0.004	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—liver cancer	0.000247	0.00397	CcSEcCtD
Rosiglitazone—Back pain—Epirubicin—liver cancer	0.000242	0.0039	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—liver cancer	0.00024	0.00387	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—liver cancer	0.000231	0.00373	CcSEcCtD
Rosiglitazone—Anaemia—Epirubicin—liver cancer	0.000231	0.00372	CcSEcCtD
Rosiglitazone—Leukopenia—Epirubicin—liver cancer	0.000224	0.00361	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—liver cancer	0.000224	0.00361	CcSEcCtD
Rosiglitazone—Hypertension—Epirubicin—liver cancer	0.000216	0.00348	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—liver cancer	0.000214	0.00345	CcSEcCtD
Rosiglitazone—Arthralgia—Epirubicin—liver cancer	0.000213	0.00343	CcSEcCtD
Rosiglitazone—Myalgia—Epirubicin—liver cancer	0.000213	0.00343	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—liver cancer	0.000207	0.00334	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Epirubicin—liver cancer	0.000204	0.00329	CcSEcCtD
Rosiglitazone—Oedema—Epirubicin—liver cancer	0.000204	0.00329	CcSEcCtD
Rosiglitazone—Infection—Epirubicin—liver cancer	0.000203	0.00327	CcSEcCtD
Rosiglitazone—Nervous system disorder—Epirubicin—liver cancer	0.0002	0.00322	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Epirubicin—liver cancer	0.0002	0.00322	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—liver cancer	0.0002	0.00322	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—liver cancer	0.000197	0.00317	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—liver cancer	0.000197	0.00317	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—liver cancer	0.000189	0.00304	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—liver cancer	0.000189	0.00304	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—liver cancer	0.000188	0.00302	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000186	0.003	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—liver cancer	0.000185	0.00298	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—liver cancer	0.000185	0.00298	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000176	0.00284	CcSEcCtD
Rosiglitazone—Fatigue—Epirubicin—liver cancer	0.000176	0.00283	CcSEcCtD
Rosiglitazone—Constipation—Epirubicin—liver cancer	0.000175	0.00281	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000172	0.00277	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000163	0.00263	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—liver cancer	0.000163	0.00262	CcSEcCtD
Rosiglitazone—Urticaria—Epirubicin—liver cancer	0.000162	0.00261	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—liver cancer	0.000162	0.0026	CcSEcCtD
Rosiglitazone—Urticaria—Doxorubicin—liver cancer	0.00015	0.00242	CcSEcCtD
Rosiglitazone—Asthenia—Epirubicin—liver cancer	0.000146	0.00236	CcSEcCtD
Rosiglitazone—Pruritus—Epirubicin—liver cancer	0.000144	0.00233	CcSEcCtD
Rosiglitazone—Diarrhoea—Epirubicin—liver cancer	0.00014	0.00225	CcSEcCtD
Rosiglitazone—Asthenia—Doxorubicin—liver cancer	0.000136	0.00218	CcSEcCtD
Rosiglitazone—Dizziness—Epirubicin—liver cancer	0.000135	0.00217	CcSEcCtD
Rosiglitazone—Pruritus—Doxorubicin—liver cancer	0.000134	0.00215	CcSEcCtD
Rosiglitazone—Diarrhoea—Doxorubicin—liver cancer	0.000129	0.00208	CcSEcCtD
Rosiglitazone—Rash—Epirubicin—liver cancer	0.000129	0.00207	CcSEcCtD
Rosiglitazone—Dermatitis—Epirubicin—liver cancer	0.000129	0.00207	CcSEcCtD
Rosiglitazone—Headache—Epirubicin—liver cancer	0.000128	0.00206	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—liver cancer	0.000125	0.00201	CcSEcCtD
Rosiglitazone—Nausea—Epirubicin—liver cancer	0.000121	0.00195	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—liver cancer	0.000119	0.00192	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—liver cancer	0.000119	0.00192	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—liver cancer	0.000118	0.00191	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—liver cancer	0.000112	0.00181	CcSEcCtD
Rosiglitazone—PPARG—Developmental Biology—HRAS—liver cancer	1.56e-05	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GGT1—liver cancer	1.55e-05	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GOT1—liver cancer	1.55e-05	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTA4—liver cancer	1.55e-05	0.000116	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CPT1B—liver cancer	1.52e-05	0.000115	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GLUL—liver cancer	1.52e-05	0.000115	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTA2—liver cancer	1.52e-05	0.000115	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTM1—liver cancer	1.52e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.52e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALDOB—liver cancer	1.51e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.51e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTA2—liver cancer	1.51e-05	0.000114	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.5e-05	0.000113	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—IL6—liver cancer	1.49e-05	0.000112	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTP1—liver cancer	1.47e-05	0.000111	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NR1H4—liver cancer	1.47e-05	0.000111	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTA1—liver cancer	1.47e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.45e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTA1—liver cancer	1.45e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NAT2—liver cancer	1.45e-05	0.000109	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—HMOX1—liver cancer	1.45e-05	0.000109	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.45e-05	0.000109	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTA3—liver cancer	1.44e-05	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CRABP1—liver cancer	1.44e-05	0.000109	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.44e-05	0.000108	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP1A1—liver cancer	1.44e-05	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NAT2—liver cancer	1.44e-05	0.000108	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CG—liver cancer	1.43e-05	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HPGDS—liver cancer	1.41e-05	0.000106	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HPGDS—liver cancer	1.4e-05	0.000106	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.4e-05	0.000106	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CD—liver cancer	1.4e-05	0.000105	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.4e-05	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALDOB—liver cancer	1.39e-05	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTP1—liver cancer	1.39e-05	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.38e-05	0.000104	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SERPINE1—liver cancer	1.38e-05	0.000104	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALDOB—liver cancer	1.38e-05	0.000104	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—liver cancer	1.37e-05	0.000103	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—HMOX1—liver cancer	1.37e-05	0.000103	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTM1—liver cancer	1.35e-05	0.000102	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—MTHFR—liver cancer	1.34e-05	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CRABP1—liver cancer	1.33e-05	9.99e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTA4—liver cancer	1.32e-05	9.96e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARA—liver cancer	1.32e-05	9.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CRABP1—liver cancer	1.31e-05	9.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.3e-05	9.78e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.29e-05	9.73e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTA2—liver cancer	1.29e-05	9.7e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP1A1—liver cancer	1.28e-05	9.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.28e-05	9.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTM1—liver cancer	1.28e-05	9.62e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.27e-05	9.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.26e-05	9.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HPGDS—liver cancer	1.26e-05	9.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PSMA4—liver cancer	1.26e-05	9.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PSMD10—liver cancer	1.26e-05	9.48e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CD—liver cancer	1.26e-05	9.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.25e-05	9.44e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PSMD10—liver cancer	1.25e-05	9.43e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PSMA4—liver cancer	1.25e-05	9.43e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RAF1—liver cancer	1.25e-05	9.39e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—liver cancer	1.24e-05	9.36e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTA1—liver cancer	1.24e-05	9.36e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NAT2—liver cancer	1.23e-05	9.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GOT2—liver cancer	1.22e-05	9.22e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GOT2—liver cancer	1.22e-05	9.17e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CB—liver cancer	1.22e-05	9.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP1A1—liver cancer	1.21e-05	9.12e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—MTHFR—liver cancer	1.19e-05	8.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.18e-05	8.92e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.18e-05	8.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.18e-05	8.9e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDOB—liver cancer	1.18e-05	8.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.18e-05	8.86e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARA—liver cancer	1.17e-05	8.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HPGDS—liver cancer	1.16e-05	8.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP2E1—liver cancer	1.15e-05	8.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HPGDS—liver cancer	1.15e-05	8.66e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP2E1—liver cancer	1.14e-05	8.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.14e-05	8.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.14e-05	8.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MTHFR—liver cancer	1.13e-05	8.5e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CG—liver cancer	1.13e-05	8.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.13e-05	8.49e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CRABP1—liver cancer	1.12e-05	8.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PSMA4—liver cancer	1.12e-05	8.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PSMD10—liver cancer	1.12e-05	8.46e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2—liver cancer	1.12e-05	8.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.11e-05	8.4e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.11e-05	8.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARA—liver cancer	1.11e-05	8.34e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CB—liver cancer	1.1e-05	8.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GOT2—liver cancer	1.09e-05	8.23e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—liver cancer	1.09e-05	8.2e-05	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.08e-05	8.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYCS—liver cancer	1.08e-05	8.11e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYCS—liver cancer	1.07e-05	8.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GOT1—liver cancer	1.06e-05	7.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GGT1—liver cancer	1.06e-05	7.96e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.05e-05	7.92e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GGT1—liver cancer	1.05e-05	7.92e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GOT1—liver cancer	1.05e-05	7.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.04e-05	7.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSMD10—liver cancer	1.03e-05	7.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSMA4—liver cancer	1.03e-05	7.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP2E1—liver cancer	1.03e-05	7.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.03e-05	7.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSMA4—liver cancer	1.02e-05	7.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSMD10—liver cancer	1.02e-05	7.72e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—liver cancer	1.01e-05	7.63e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.01e-05	7.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GOT2—liver cancer	1.01e-05	7.57e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CG—liver cancer	1e-05	7.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GOT2—liver cancer	9.96e-06	7.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.95e-06	7.49e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CD—liver cancer	9.91e-06	7.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HPGDS—liver cancer	9.82e-06	7.4e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—liver cancer	9.78e-06	7.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.76e-06	7.36e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—liver cancer	9.68e-06	7.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYCS—liver cancer	9.61e-06	7.24e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—liver cancer	9.5e-06	7.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—liver cancer	9.49e-06	7.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—liver cancer	9.48e-06	7.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2E1—liver cancer	9.45e-06	7.12e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—liver cancer	9.44e-06	7.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GOT1—liver cancer	9.43e-06	7.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GGT1—liver cancer	9.43e-06	7.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2E1—liver cancer	9.37e-06	7.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—liver cancer	9.36e-06	7.05e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—liver cancer	9.31e-06	7.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—liver cancer	9.15e-06	6.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.07e-06	6.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.89e-06	6.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYCS—liver cancer	8.84e-06	6.66e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CD—liver cancer	8.82e-06	6.64e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.78e-06	6.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYCS—liver cancer	8.77e-06	6.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSMA4—liver cancer	8.75e-06	6.59e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSMD10—liver cancer	8.75e-06	6.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—liver cancer	8.72e-06	6.57e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—liver cancer	8.72e-06	6.57e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—liver cancer	8.7e-06	6.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GGT1—liver cancer	8.68e-06	6.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GOT1—liver cancer	8.68e-06	6.54e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—liver cancer	8.67e-06	6.54e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CB—liver cancer	8.64e-06	6.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GGT1—liver cancer	8.6e-06	6.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GOT1—liver cancer	8.6e-06	6.48e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GOT2—liver cancer	8.51e-06	6.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—liver cancer	8.47e-06	6.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—liver cancer	8.36e-06	6.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CD—liver cancer	8.34e-06	6.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP1A1—liver cancer	8.27e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—liver cancer	8.23e-06	6.2e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP1A1—liver cancer	8.22e-06	6.2e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—liver cancer	8.08e-06	6.09e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2E1—liver cancer	8.01e-06	6.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—liver cancer	7.79e-06	5.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—liver cancer	7.79e-06	5.87e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.75e-06	5.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—liver cancer	7.73e-06	5.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—liver cancer	7.71e-06	5.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—liver cancer	7.69e-06	5.79e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CB—liver cancer	7.68e-06	5.79e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—liver cancer	7.67e-06	5.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—liver cancer	7.62e-06	5.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARA—liver cancer	7.56e-06	5.7e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARA—liver cancer	7.52e-06	5.67e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYCS—liver cancer	7.49e-06	5.64e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—liver cancer	7.42e-06	5.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1A1—liver cancer	7.38e-06	5.56e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GGT1—liver cancer	7.35e-06	5.54e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GOT1—liver cancer	7.35e-06	5.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CB—liver cancer	7.27e-06	5.47e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—liver cancer	7.18e-06	5.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—liver cancer	7.16e-06	5.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—liver cancer	7.1e-06	5.35e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—liver cancer	7.02e-06	5.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—liver cancer	6.88e-06	5.18e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—liver cancer	6.86e-06	5.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.79e-06	5.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1A1—liver cancer	6.79e-06	5.12e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.76e-06	5.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARA—liver cancer	6.75e-06	5.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1A1—liver cancer	6.73e-06	5.07e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—liver cancer	6.69e-06	5.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—liver cancer	6.6e-06	4.97e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—liver cancer	6.51e-06	4.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—liver cancer	6.48e-06	4.88e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—liver cancer	6.44e-06	4.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—liver cancer	6.33e-06	4.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—liver cancer	6.27e-06	4.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—liver cancer	6.25e-06	4.71e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—liver cancer	6.22e-06	4.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARA—liver cancer	6.21e-06	4.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARA—liver cancer	6.16e-06	4.64e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—liver cancer	6.07e-06	4.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.06e-06	4.57e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—liver cancer	6.06e-06	4.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—liver cancer	5.78e-06	4.36e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP1A1—liver cancer	5.75e-06	4.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CD—liver cancer	5.69e-06	4.29e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CD—liver cancer	5.66e-06	4.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—liver cancer	5.62e-06	4.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—liver cancer	5.58e-06	4.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.53e-06	4.17e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—liver cancer	5.46e-06	4.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—liver cancer	5.36e-06	4.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—liver cancer	5.32e-06	4.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—liver cancer	5.27e-06	3.97e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—liver cancer	5.27e-06	3.97e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARA—liver cancer	5.26e-06	3.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—liver cancer	5.13e-06	3.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—liver cancer	5.09e-06	3.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CD—liver cancer	5.08e-06	3.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—liver cancer	5.02e-06	3.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CB—liver cancer	4.96e-06	3.74e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CB—liver cancer	4.94e-06	3.72e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.72e-06	3.56e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—liver cancer	4.68e-06	3.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CD—liver cancer	4.67e-06	3.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CD—liver cancer	4.63e-06	3.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—liver cancer	4.61e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—liver cancer	4.57e-06	3.45e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—liver cancer	4.5e-06	3.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CB—liver cancer	4.43e-06	3.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—liver cancer	4.43e-06	3.34e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—liver cancer	4.35e-06	3.28e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—liver cancer	4.3e-06	3.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CB—liver cancer	4.07e-06	3.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CB—liver cancer	4.04e-06	3.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CD—liver cancer	3.96e-06	2.98e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—liver cancer	3.91e-06	2.95e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—liver cancer	3.83e-06	2.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—liver cancer	3.62e-06	2.73e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CB—liver cancer	3.45e-06	2.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—liver cancer	3.03e-06	2.28e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—liver cancer	3.01e-06	2.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—liver cancer	2.7e-06	2.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—liver cancer	2.48e-06	1.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—liver cancer	2.47e-06	1.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—liver cancer	2.46e-06	1.86e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—liver cancer	2.46e-06	1.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—liver cancer	2.21e-06	1.66e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—liver cancer	2.1e-06	1.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—liver cancer	2.03e-06	1.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—liver cancer	2.01e-06	1.52e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—liver cancer	1.72e-06	1.3e-05	CbGpPWpGaD
